Testing effectiveness (Phase 2)Study completedNCT04328727
What this trial is testing
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
Who this might be right for
Severe Aplastic Anemia (SAA)
Novartis Pharmaceuticals 36